![glp 1 agonist metformin New aspects of an old drug: as a glucagon-like peptide (GLP-1) enhancer and sensitiser | Diabetologia glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00125-010-1986-3/MediaObjects/125_2010_1986_Fig1_HTML.gif)
glp 1 agonist metformin New aspects of an old drug: as a glucagon-like peptide (GLP-1) enhancer and sensitiser | Diabetologia glp-1_analogs [TUSOM | Pharmwiki]
Description
Studies show that GLP-1s decrease pain/stiffness, protect cartilage, and improve mobility, possibly preventing surgery for some
![glp 1 agonist metformin New aspects of an old drug: as a glucagon-like peptide (GLP-1) enhancer and sensitiser | Diabetologia glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
The highlight of our work is to investigate immune cell biology directly and explore how GLP-1RAs influence disease by affecting the biological functions of relevant immune cells, providing important directions for future research
![glp 1 agonist metformin New aspects of an old drug: as a glucagon-like peptide (GLP-1) enhancer and sensitiser | Diabetologia glp-1_analogs [TUSOM | Pharmwiki]](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56f6/12504844/32e052d27ede/10.1177_20420188251383064-fig3.jpg)
Reduction of serum soluble CD26/dipeptidylpeptidase IV enzyme activity and its correlation withdisease activity in systemic lupus erythematosus
![glp 1 agonist metformin New aspects of an old drug: as a glucagon-like peptide (GLP-1) enhancer and sensitiser | Diabetologia glp-1_analogs [TUSOM | Pharmwiki]](https://amwa-doc.org/wp-content/uploads/2025/12/image-3-1.jpg)
doi: 10.2174/138161212799315786 [DOI] [PMC free article] [PubMed] [Google Scholar] 128
![glp 1 agonist metformin New aspects of an old drug: as a glucagon-like peptide (GLP-1) enhancer and sensitiser | Diabetologia glp-1_analogs [TUSOM | Pharmwiki]](https://www.researchgate.net/publication/387719938/figure/fig4/AS:11431281388598887@1745185793531/Diagram-summarizing-how-metformin-gliclazide-GLP-1-receptor-agonists-and-SGLT-2_Q320.jpg)
